Global $10+ Bn Blood Glucose Monitoring Devices Market to 2025 by Product, End-user, Geography and Impact of Covid-19 with Ansoff's Analysis

Research and Markets
·4-min read

Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Global Blood Glucose Monitoring Devices Market 2020-2025 by Product, End-user, Geography and Impact of Covid-19 with Ansoff's Analysis" report has been added to's offering.

The Global Biostimulants Market is estimated to be USD 10.1 Bn in 2020 and is expected to reach USD 14.4 Bn by 2025 growing at a CAGR of 7.3%.

Diabetes has been considered as one of the chronic diseases affecting people of diverse age groups across the globe. Preventive care against diabetes and effective management can be done with the available Blood glucose monitoring devices in the market. Similarly, Blood glucose monitoring systems is a device used for monitoring the levels of blood sugar and the diagnosis of diabetes. These monitors vary in size, price, and its stated length of testing time.

Factors such as an increasing patient pool belonging to the diabetic category due to the increasing prevalence of diabetes have supported the growth of this market. Conversely, the presence of alternative cheaper substitutes shall hinder the growth of this market.

Company Profiles
Some of the companies covered in this report are Abbott Laboratories, ARKRAY, Inc., Bayer AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, and Terumo Medical Corporation

Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share etc.

Market Dynamics


  • Rising geriatric population worldwide

  • Increasing number of patients with obesity and diabetes

  • Mere ease of use


  • The high cost of devices

  • Presence of substitutes


  • Increasing awareness about the point of care testing (POCT)

  • Technological advancements in healthcare


  • Adoption to portable healthcare platforms

Key Topics Covered:

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Trends

5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Blood Glucose Monitoring Devices Market, By Product
6.1 Self-Monitoring Devices
6.1.1 Blood glucose meters market
6.1.2 Testing strips
6.1.3 Lancets
6.2 Continuous Blood Glucose Monitoring Devices
6.2.1 Sensors
6.2.2 Transmitter and receiver
6.3 Insulin pumps

7 Global Blood Glucose Monitoring Devices Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Homecare
7.4 Diagnostic Centers

8 Global Blood Glucose Monitoring Devices Market, By Geography

9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Competitive Scenario
9.3.1 Merger & Acquisition
9.3.2 Agreement, Collaboration, & Partnership
9.3.3 New Product Launch & Enhancement
9.3.4 Investment & Funding

10 Company Profiles
10.1 Abbott Laboratories
10.2 Medtronic plc
10.3 F. Hoffmann-La Roche Ltd
10.4 Bayer AG
10.5 Lifescan, Inc
10.6 B. Braun Melsungen AG,
10.7 Sanofi
10.8 Eli Lilly and Company
10.9 FMC Corporation
10.10 Adama
10.11 Koppert Biological Systems
10.12 Acadian Seaplants Limited
10.13 Biovert-Manvert
10.14 Haifa Group
10.15 SAPEC
10.16 Arkay, Inc
10.17 Dexcom, Inc.
10.18 Johnson & Johnson
10.19 Terumo Medical Corporation

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900